Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2025-12-25 @ 9:49 PM
NCT ID: NCT03046251
Description: Serious side effects Infections Jaundice Anemia Allergy or infection in the brain Acute hypersensitivity reactions Cholelithiasis Common side effects Headache Fatigue Urinary tract infection Joint pain Lung infection Depression Pain in arms or legs Diarrhea Vaginitis Rash Relapse not requiring hospitalization
Frequency Threshold: 0
Time Frame: 52 weeks
Study: NCT03046251
Study Brief: Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Natalizumab Participants in this group are those who opt to receive treatment with natalizumab IV 300mg/day given q 4 weeks for 48 weeks. Natalizumab 0 None 0 4 2 4 View
Control Participants in this group may initiate any FDA approved DMT at any time post delivery or remain on no therapy. 0 None 0 26 7 26 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
MS relapse NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View